JP Stock MarketDetailed Quotes

Fuso Pharmaceutical Industries (4538)

Watchlist
  • 2045
  • +33+1.64%
20min DelayMarket Closed May 14 15:30 JST
19.33BMarket Cap-5.31P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Fuso Pharmaceutical Industries (4538) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
Total revenue
6.03%15.5B
9.31%60.56B
8.25%14.62B
8.61%55.41B
6.61%12.58B
11.25%15.41B
7.02%13.92B
9.22%13.51B
2.79%51.02B
3.83%11.8B
Cost of revenue
9.33%11.42B
5.93%44.03B
4.47%10.45B
11.52%41.57B
8.74%9.45B
12.82%11.58B
11.25%10.55B
13.03%10B
2.87%37.27B
4.07%8.69B
Gross profit
-2.25%4.08B
19.47%16.53B
19.06%4.17B
0.71%13.84B
0.68%3.13B
6.77%3.83B
-4.31%3.37B
-0.40%3.5B
2.56%13.74B
3.12%3.11B
Operating expense
15.22%3.48B
4.44%12.4B
3.71%3.02B
2.96%11.87B
4.92%3.01B
6.19%3.09B
0.03%2.86B
0.66%2.91B
0.52%11.53B
-5.10%2.87B
Operating profit
-48.17%596M
110.34%4.13B
94.92%1.15B
-11.01%1.96B
-49.79%121M
9.25%744M
-23.11%509M
-5.30%590M
14.71%2.21B
3,542.86%241M
Net non-operating interest income (expenses)
-171.43%-10M
28.00%-54M
75.00%14M
1.32%-75M
-10.26%-43M
57.14%-3M
11.90%-37M
-33.33%8M
19.15%-76M
4.88%-39M
Non-operating interest income
15.38%60M
11.46%107M
13.04%52M
7.87%96M
0.00%1M
19.44%43M
500.00%6M
-9.80%46M
8.54%89M
0.00%1M
Non-operating interest expense
84.21%70M
-5.85%161M
0.00%38M
3.64%171M
10.00%44M
6.98%46M
0.00%43M
-2.56%38M
-6.25%165M
-4.76%40M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
0
-117.95%-7M
-157.97%-80M
-9M
-9M
-274.14%-101M
-51.25%39M
7,000.00%138M
0
Income from associates and other participating interests
Special income (charges)
-8.77%52M
-21,807.50%-8.76B
21.28%57M
-53.85%-40M
18.52%-22M
-45.83%-35M
-3.45%-30M
-12.96%47M
-168.42%-26M
-775.00%-27M
Less:Other special charges
8.77%-52M
21,807.50%8.76B
-21.28%-57M
53.85%40M
-18.52%22M
45.83%35M
3.45%30M
12.96%-47M
168.42%26M
775.00%27M
Other non-operating income (expenses)
102.56%8M
-28,300.00%-284M
-3,566.67%-312M
97.22%-1M
19.05%-17M
41.67%17M
68.75%-10M
80.00%9M
-176.60%-36M
-170.00%-21M
Income before tax
-28.19%647M
-381.27%-4.97B
30.20%901M
-19.86%1.77B
-80.92%29M
7.70%713M
-46.03%333M
-10.59%692M
15.38%2.21B
278.82%152M
Income tax
-31.60%184M
-532.39%-1.68B
26.89%269M
-35.06%389M
-402.50%-121M
8.60%202M
-39.62%96M
-0.93%212M
40.28%599M
154.05%40M
Net income
-26.90%462M
-338.78%-3.29B
31.94%632M
-14.21%1.38B
33.93%150M
7.37%510M
-48.15%238M
-14.31%479M
8.23%1.61B
1,033.33%112M
Net income continuous operations
-26.74%463M
-338.61%-3.29B
31.67%632M
-14.20%1.38B
33.93%150M
7.35%511M
-48.25%237M
-14.29%480M
8.22%1.61B
1,118.18%112M
Noncontrolling interests
Net income attributable to the company
-26.90%462M
-338.78%-3.29B
31.94%632M
-14.21%1.38B
33.93%150M
7.37%510M
-48.15%238M
-14.31%479M
8.23%1.61B
1,033.33%112M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-26.90%462M
-338.78%-3.29B
31.94%632M
-14.21%1.38B
33.93%150M
7.37%510M
-48.15%238M
-14.31%479M
8.23%1.61B
1,033.33%112M
Gross dividend payment
Basic earnings per share
-26.89%54.14
-340.62%-384.95
35.35%74.05
-12.61%159.98
41.43%18.06
10.28%59.74
-47.55%27.47
-14.19%54.71
8.27%183.07
1,045.93%12.77
Diluted earnings per share
-26.89%54.14
-340.62%-384.95
35.35%74.05
-12.61%159.98
37.47%17.5547
10.32%59.74
-47.50%27.47
-14.19%54.71
8.27%183.07
1,033.48%12.77
Dividend per share
0
17.14%82
0
0.00%70
-12.50%35
0
16.67%35
0
16.67%70
33.33%40
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023
Total revenue 6.03%15.5B9.31%60.56B8.25%14.62B8.61%55.41B6.61%12.58B11.25%15.41B7.02%13.92B9.22%13.51B2.79%51.02B3.83%11.8B
Cost of revenue 9.33%11.42B5.93%44.03B4.47%10.45B11.52%41.57B8.74%9.45B12.82%11.58B11.25%10.55B13.03%10B2.87%37.27B4.07%8.69B
Gross profit -2.25%4.08B19.47%16.53B19.06%4.17B0.71%13.84B0.68%3.13B6.77%3.83B-4.31%3.37B-0.40%3.5B2.56%13.74B3.12%3.11B
Operating expense 15.22%3.48B4.44%12.4B3.71%3.02B2.96%11.87B4.92%3.01B6.19%3.09B0.03%2.86B0.66%2.91B0.52%11.53B-5.10%2.87B
Operating profit -48.17%596M110.34%4.13B94.92%1.15B-11.01%1.96B-49.79%121M9.25%744M-23.11%509M-5.30%590M14.71%2.21B3,542.86%241M
Net non-operating interest income (expenses) -171.43%-10M28.00%-54M75.00%14M1.32%-75M-10.26%-43M57.14%-3M11.90%-37M-33.33%8M19.15%-76M4.88%-39M
Non-operating interest income 15.38%60M11.46%107M13.04%52M7.87%96M0.00%1M19.44%43M500.00%6M-9.80%46M8.54%89M0.00%1M
Non-operating interest expense 84.21%70M-5.85%161M0.00%38M3.64%171M10.00%44M6.98%46M0.00%43M-2.56%38M-6.25%165M-4.76%40M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets 0-117.95%-7M-157.97%-80M-9M-9M-274.14%-101M-51.25%39M7,000.00%138M0
Income from associates and other participating interests
Special income (charges) -8.77%52M-21,807.50%-8.76B21.28%57M-53.85%-40M18.52%-22M-45.83%-35M-3.45%-30M-12.96%47M-168.42%-26M-775.00%-27M
Less:Other special charges 8.77%-52M21,807.50%8.76B-21.28%-57M53.85%40M-18.52%22M45.83%35M3.45%30M12.96%-47M168.42%26M775.00%27M
Other non-operating income (expenses) 102.56%8M-28,300.00%-284M-3,566.67%-312M97.22%-1M19.05%-17M41.67%17M68.75%-10M80.00%9M-176.60%-36M-170.00%-21M
Income before tax -28.19%647M-381.27%-4.97B30.20%901M-19.86%1.77B-80.92%29M7.70%713M-46.03%333M-10.59%692M15.38%2.21B278.82%152M
Income tax -31.60%184M-532.39%-1.68B26.89%269M-35.06%389M-402.50%-121M8.60%202M-39.62%96M-0.93%212M40.28%599M154.05%40M
Net income -26.90%462M-338.78%-3.29B31.94%632M-14.21%1.38B33.93%150M7.37%510M-48.15%238M-14.31%479M8.23%1.61B1,033.33%112M
Net income continuous operations -26.74%463M-338.61%-3.29B31.67%632M-14.20%1.38B33.93%150M7.35%511M-48.25%237M-14.29%480M8.22%1.61B1,118.18%112M
Noncontrolling interests
Net income attributable to the company -26.90%462M-338.78%-3.29B31.94%632M-14.21%1.38B33.93%150M7.37%510M-48.15%238M-14.31%479M8.23%1.61B1,033.33%112M
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders -26.90%462M-338.78%-3.29B31.94%632M-14.21%1.38B33.93%150M7.37%510M-48.15%238M-14.31%479M8.23%1.61B1,033.33%112M
Gross dividend payment
Basic earnings per share -26.89%54.14-340.62%-384.9535.35%74.05-12.61%159.9841.43%18.0610.28%59.74-47.55%27.47-14.19%54.718.27%183.071,045.93%12.77
Diluted earnings per share -26.89%54.14-340.62%-384.9535.35%74.05-12.61%159.9837.47%17.554710.32%59.74-47.50%27.47-14.19%54.718.27%183.071,033.48%12.77
Dividend per share 017.14%8200.00%70-12.50%35016.67%35016.67%7033.33%40
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.66%
Sample Name
Sample Code
 +3.12%
Sample Name
Sample Code
 +1.57%
4
CNOOC
00883
+0.76%
5
SINOPEC CORP
00386
+0.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +47.30%
Sample Name
Sample Code
 +42.24%
Sample Name
Sample Code
 +30.17%
4
Loongson Technology Corporation
688047
+19.58%
5
Digital China Group
000034
+16.92%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -